As of Feb 12
| +0.02 / +0.57%|
The 8 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 11.50, with a high estimate of 20.00 and a low estimate of 6.00. The median estimate represents a +223.94% increase from the last price of 3.55.
The current consensus among 8 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.